Study in Participants With Acute Migraines Headaches
Launched by ELI LILLY AND COMPANY · Dec 5, 2008
Trial Information
Current as of May 22, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female participants between the ages of 18 and 65 years, inclusive.
- • Participants who have migraine headaches, with or without aura (diagnosis according the International Classification of Headache Disorders-II), for at least 1 year.
- • Participants who have had 2-8 migraine attacks on average per month for the last 3 months (but less than 15 headache days per month).
- • Participants who are willing and able to comply with the study schedule and requirements.
- • Participants who speak, read, and understand English sufficiently well and are willing to provide written informed consent.
- • Participants who in the opinion of the principal investigator are in good general health.
- • Venous access should be sufficient to allow blood sampling as per protocol.
- Exclusion Criteria:
- • Participants who do not or may not tolerate 5HT1 agonist treatments, with known hypersensitivity to sumatriptan (as discussed with the investigator).
- • Female participants who have a positive pregnancy test at screening or pre- dose evaluation, or are breastfeeding.
- • History or presence of significant medical illnesses as determined by the investigator.
- • Participants with a current clinical diagnosis of major psychiatric disease.
- • Regular use of known drugs of abuse; use of opiates for migraine rescue (no more than two times per month) is permissible.
- • Blood donation of 500 milliliter (mL) or greater of whole blood products within 4 weeks of study commencement, during the study, or 4 weeks following the study.
- • Investigator site personnel directly affiliated with this study and their immediate families. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
- • Consumption of more than three units of alcohol per day where one unit is defined as a 12 ounces (oz) beer, 4 oz wine, or 2 oz of alcohol spirit liquor.
- • Are unwilling or unable to comply with the use of a diary to directly record data from the participant.
About Eli Lilly And Company
Eli Lilly and Company is a global healthcare leader dedicated to creating innovative medicines that improve patient outcomes across a range of therapeutic areas, including diabetes, oncology, immunology, and neurodegenerative diseases. With a rich history of scientific research and a commitment to advancing healthcare, Lilly invests significantly in clinical trials to develop new treatments and enhance existing therapies. The company prioritizes patient safety and ethical standards in its clinical research, fostering collaboration with healthcare professionals and stakeholders to ensure the delivery of high-quality, evidence-based solutions that address unmet medical needs worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Norfolk, Virginia, United States
Beverly Hills, California, United States
Fresno, California, United States
Memphis, Tennessee, United States
Garden Grove, California, United States
Philadelphia, Pennsylvania, United States
West Palm Beach, Florida, United States
Philadelphia, Pennsylvania, United States
Santa Monica, California, United States
Ann Arbor, Michigan, United States
San Francisco, California, United States
Wellesley Hills, Massachusetts, United States
Chula Vista, California, United States
Imperial, California, United States
Chicago, Illinois, United States
Mount Vernon, New York, United States
West Chester, Ohio, United States
Austin, Texas, United States
Houston, Texas, United States
Patients applied
Trial Officials
Call 1-877-CTLILLY or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials